The antidiabetic effect of ginsenoside Rb2 via activation of AMPK
- Authors
- Lee, Kyoung-Tae; Jung, Tae Woo; Lee, Hak-Ju; Kim, Seul-Gi; Shin, Yu-Su; Whang, Wan-Kyunn
- Issue Date
- Jul-2011
- Publisher
- PHARMACEUTICAL SOC KOREA
- Keywords
- Panax ginseng; Rb2; AMPK; SHP; H4IIE cells
- Citation
- ARCHIVES OF PHARMACAL RESEARCH, v.34, no.7, pp 1201 - 1208
- Pages
- 8
- Journal Title
- ARCHIVES OF PHARMACAL RESEARCH
- Volume
- 34
- Number
- 7
- Start Page
- 1201
- End Page
- 1208
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/21444
- DOI
- 10.1007/s12272-011-0719-6
- ISSN
- 0253-6269
1976-3786
- Abstract
- Ginsenosides, which are active compounds found in ginseng (Panax ginseng), are used as antidiabetic treatments. The aim of this study was to determine whether Rb2, a type of ginsenoside, regulates hepatic gluconeogenesis through AMP-activated protein kinase (AMPK) and the orphan nuclear receptor small heterodimer partner (SHP) in hyperlipidemic conditions used as an in vitro model of type 2 diabetes. Considering these results, we concluded that Rb2 may inhibit palmitate-induced gluconeogenesis via AMPK-induced SHP by relieving ER stress, a cause of gluconeogenesis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/21444)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.